MYXC2_CRODM
ID MYXC2_CRODM Reviewed; 42 AA.
AC P86193;
DT 05-MAY-2009, integrated into UniProtKB/Swiss-Prot.
DT 05-MAY-2009, sequence version 1.
DT 25-MAY-2022, entry version 26.
DE RecName: Full=Crotamine-IV-2 {ECO:0000303|PubMed:17828447};
OS Crotalus durissus cumanensis (South American rattlesnake).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata; Toxicofera;
OC Serpentes; Colubroidea; Viperidae; Crotalinae; Crotalus.
OX NCBI_TaxID=184542;
RN [1]
RP PROTEIN SEQUENCE, FUNCTION, MASS SPECTROMETRY, TOXIC DOSE, AND SUBCELLULAR
RP LOCATION.
RC TISSUE=Venom;
RX PubMed=17828447; DOI=10.1007/s10930-007-9094-z;
RA Ponce-Soto L.A., Martins D., Novello J.C., Marangoni S.;
RT "Structural and biological characterization of two crotamine isoforms IV-2
RT and IV-3 isolated from the Crotalus durissus cumanensis venom.";
RL Protein J. 26:533-540(2007).
CC -!- FUNCTION: Cationic peptide that possesses multiple functions. It acts
CC as a cell-penetrating peptide (CPP), and as a potent voltage-gated
CC potassium channel (Kv) inhibitor. It exhibits antimicrobial activities,
CC and hind limb paralysis (By similarity). It also induces potent
CC blockade of neuromuscular transmission in young chicken biventer
CC cervicis preparation and potent myotoxic effect. In mice, it induces
CC myonecrosis, upon intramuscular or subcutaneous injections
CC (PubMed:17828447). {ECO:0000250|UniProtKB:Q9PWF3,
CC ECO:0000269|PubMed:17828447}.
CC -!- SUBUNIT: Monomer. {ECO:0000250}.
CC -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:17828447}.
CC -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC {ECO:0000305|PubMed:17828447}.
CC -!- MASS SPECTROMETRY: Mass=4905.95; Method=Electrospray;
CC Evidence={ECO:0000269|PubMed:17828447};
CC -!- TOXIC DOSE: LD(50) is 0.07 mg/kg by intracerebroventricular injection
CC into mice. {ECO:0000269|PubMed:17828447}.
CC -!- SIMILARITY: Belongs to the crotamine-myotoxin family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR AlphaFoldDB; P86193; -.
DR SMR; P86193; -.
DR TCDB; 1.C.85.2.2; the pore-forming Beta-defensin (Beta-defensin) family.
DR GO; GO:0005576; C:extracellular region; IDA:UniProtKB.
DR GO; GO:0015459; F:potassium channel regulator activity; IEA:UniProtKB-KW.
DR GO; GO:0090729; F:toxin activity; IDA:UniProtKB.
DR GO; GO:0044534; P:envenomation resulting in modulation of apoptotic process in another organism; IDA:UniProtKB.
DR GO; GO:0044521; P:envenomation resulting in muscle damage in another organism; IDA:UniProtKB.
DR GO; GO:0044564; P:envenomation resulting in occlusion of the pore of voltage-gated potassium channel in another organism; ISS:UniProtKB.
DR Gene3D; 2.20.20.10; -; 1.
DR InterPro; IPR023355; Myo_ane_neurotoxin_sf.
DR InterPro; IPR000881; Myotoxin.
DR Pfam; PF00819; Myotoxins; 1.
DR PRINTS; PR00283; MYOTOXIN.
DR PROSITE; PS51345; MYOTOXINS_2; 1.
PE 1: Evidence at protein level;
KW Antimicrobial; Direct protein sequencing; Disulfide bond;
KW Ion channel impairing toxin; Myotoxin; Neurotoxin;
KW Potassium channel impairing toxin; Secreted; Toxin;
KW Voltage-gated potassium channel impairing toxin.
FT CHAIN 1..42
FT /note="Crotamine-IV-2"
FT /evidence="ECO:0000269|PubMed:17828447"
FT /id="PRO_0000371460"
FT DISULFID 4..37
FT /evidence="ECO:0000250|UniProtKB:Q9PWF3"
FT DISULFID 11..31
FT /evidence="ECO:0000250|UniProtKB:Q9PWF3"
FT DISULFID 19..38
FT /evidence="ECO:0000250|UniProtKB:Q9PWF3"
SQ SEQUENCE 42 AA; 4907 MW; F542A192A9C5B90E CRC64;
YKRCHIKGGH CFPKEKLICI PPSSDIGKMD CPWKRKCCKK RS